Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Multiple Sclerosis

Free Subscription 27.10.2025 1 Arch Phys Med Rehabil 4 J Neurol 3 J Neurol Neurosurg Psychiatry 1 J Neurol Sci 4 Mult Scler 1 N Engl J Med 1 Nat Med 4 Neurology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Phys Med Rehabil

1. AYTUTULDU GK, Yalcinkaya D, Akinci B, Ucgun H, et al
   Effects of a Hybrid Telerehabilitation Model on Mobility and Functional Capacity in patients with Multiple Sclerosis: A Single Blind Randomized Controlled Study.
   Arch Phys Med Rehabil. 2025 Oct 15:S0003-9993(25)00974.
   PubMed         Abstract available
   
   

   
   J Neurol

2. ABOSEIF A, Jackson-Tarlton CS, Schwarz CG, Decker PA, et al
   Cervical cord atrophy correlates with intracranial lesion burden in tumefactive multiple sclerosis.
   J Neurol. 2025;272:717.
   PubMed         Abstract available
   
   
3. OPFER R, Spies L, Kruger J, Buddenkotte T, et al
   Whole brain volume loss is associated with a short-term disability progression in relapse-activity free multiple sclerosis.
   J Neurol. 2025;272:715.
   PubMed         Abstract available
   
   
4. SU X, Zheng Z, Yu F, Liu C, et al
   The impact of different exercise types on cognitive function in patients with multiple sclerosis: a systematic review and network meta-analysis.
   J Neurol. 2025;272:709.
   PubMed         Abstract available
   
   
5. PREZIOSA P, Brescia Morra V, Capobianco M, Gasperini C, et al
   Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion.
   J Neurol. 2025;272:707.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

6. MARIOTTINI A, Mazzeo AC, Simonetti E, Boncompagni R, et al
   Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched study.
   J Neurol Neurosurg Psychiatry. 2025 Oct 20:jnnp-2025-336808.
   PubMed         Abstract available
   
   
7. VON KAPPELGAARD L, Framke E, Vassard D, Pinborg A, et al
   Relapse activity after assisted reproductive technology treatments in women with multiple sclerosis: a nationwide cohort study in Denmark.
   J Neurol Neurosurg Psychiatry. 2025 Oct 20:jnnp-2025-336080.
   PubMed         Abstract available
   
   
8. SAMARA A, Cohen JA
   Autologous haematopoietic stem cell transplantation in multiple sclerosis: where does it fit in the treatment algorithm?
   J Neurol Neurosurg Psychiatry. 2025 Oct 20:jnnp-2025-337492.
   PubMed        
   
   

   
   J Neurol Sci

9. PIEDRABUENA MA, Correale J, Silva B, Fiol M, et al
   Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world study.
   J Neurol Sci. 2025;478:123727.
   PubMed         Abstract available
   
   

   
   Mult Scler

10. PAISEY C, Curtin K, Epps SJ, Rice CM, et al
    Acute retinal necrosis associated with dimethyl fumarate.
    Mult Scler. 2025;31:1506-1508.
    PubMed         Abstract available
    
    
11. BOFFA G, Genchi A, Mariottini A, Brittain G, et al
    Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.
    Mult Scler. 2025 Jul 7:13524585251349129. doi: 10.1177/13524585251349129.
    PubMed         Abstract available
    
    
12. REINSBERG HK, Oertel FC, Casillas D, Kaufhold G, et al
    Investigating the impact of age on neurodegeneration after optic neuritis in multiple sclerosis using optical coherence tomography.
    Mult Scler. 2025;31:1493-1505.
    PubMed         Abstract available
    
    
13. FREEDMAN DE, Campbell KA, Feinstein A
    Affective reserve in multiple sclerosis.
    Mult Scler. 2025;31:1397-1400.
    PubMed        
    
    

    
    N Engl J Med

14. RAHIMOV F, Jacobs BM, Lee JS, Mahi NA, et al
    Common Diseases in Clinical Cohorts - Not Always What They Seem.
    N Engl J Med. 2025;393:1589-1598.
    PubMed         Abstract available
    
    

    
    Nat Med

15. ABDELHAK A, Cerono G, Sheikhzadeh F, Harroud A, et al
    Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis.
    Nat Med. 2025 Oct 20. doi: 10.1038/s41591-025-04014.
    PubMed         Abstract available
    
    

    
    Neurology

16. PIERRET C, Leray E
    Author Response: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study.
    Neurology. 2025;105:e210260.
    PubMed        
    
    
17. GANESH A, Galetta SL
    Editors' Note: Understanding Cancer Risk Among Patients With Multiple Sclerosis.
    Neurology. 2025;105:e214342.
    PubMed        
    
    
18. SONG Y, Wang L, Xuan Z
    Reader Response: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study.
    Neurology. 2025;105:e210222.
    PubMed        
    
    
19. FENG Q
    Reader Response: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study.
    Neurology. 2025;105:e210223.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.